Novo resumes Wegovy 1.7 mg supply; GSK’s £200M manufacturing expansion in the UK; SmartLabs’ $48M Series C

Welcome to Endpoints News’ manufacturing news briefs, where we bring you essential updates on new builds, collaborations, recalls and more.

Novo Nordisk resumed shipments of Wegovy 1.7 mg dose earlier this month, which had been previously out of stock in the US in mid-December, a spokesperson told Endpoints. “Demand continues…
Click here to view original post